Acute and chronic tramadol administration impair spatial memory in rat

Ali Hosseini-Sharifabad, Mohammad Rabbani, Mohammad Sharifzadeh, Narges Bagheri


Tramadol hydrochloride, a synthetic opioid, acts via a multiple mechanism of action. Tramadol can potentially change the behavioral phenomena. The present study evaluates the effect of tramadol after single or multiple dose/s on the spatial memory of rat using object recognition task (ORT). Tramadol, 20 mg/kg, was injected intraperitoneally (i.p) as a single dose or once a day for 21 successive days considered as acute or chronic treatment respectively. After treatment, animals underwent two trials in the ORT. In the first trial (T1), animals encountered with two identical objects for exploration in a five-minute period. After 1 h, in the T2 trial, the animals were exposed to a familiar and a nonfamiliar object. The exploration times and frequency of the exploration for any objects were recorded. The results showed that tramadol decreased the exploration times for the nonfamiliar object in the T2 trial when administered either as a single dose (P<0.001) or as the multiple dose (P<0.05) compared to the respective control groups. Both acute and chronic tramadol administration eliminated the different frequency of exploration between the familiar and nonfamiliar objects. Our findings revealed that tramadol impaired memory when administered acutely or chronically. Single dose administration of tramadol showed more destructive effect than multiple doses of tramadol on the memory. The observed data can be explained by the inhibitory effects of tramadol on the wide range of neurotransmitters and receptors including muscarinic, N-methyl D-aspartate, AMPA as well as some second messenger like cAMP and cGMP or its stimulatory effect on the opioid, gama amino butyric acid, dopamine or serotonin in the brain.

Full Text:



Barbera N, Fisichella M, Bosco A, Indorato F, Spadaro G, Romano G. A suicidal poisoning due to tramadol. A metabolic approach to death investigation. J Forensic Leg Med. 2013;20:555-558.

Sipahi A, Satilmis T, Basa S. Comparative study in patients with symptomatic internal derangements of the temporomandibular joint: analgesic outcomes of arthrocentesis with or without intra-articular morphine and tramadol. Br J Oral Maxillofac Surg. 2015;53:316-320.

Bastami S, Haage P, Kronstrand R, Kugelberg FC, Zackrisson AL, Uppugunduri S. Pharmacogenetic aspects of tramadol pharmacokinetics and pharmacodynamics after a single oral dose. Forensic Sci Int. 2014;238:125-132.

Bloms-Funke P, Dremencov E, Cremers TI, Tzschentke TM. Tramadol increases extracellular levels of serotonin and noradrenaline as measured by in vivo microdialysis in the ventral hippocampus of freely-moving rats. Neurosci Lett. 2011;490: 191-195.

Caspani O, Reitz MC, Ceci A, Kremer A, Treede RD. Tramadol reduces anxiety-related and depression-associated behaviors presumably induced by pain in the chronic constriction injury model of neuropathic pain in rats. Pharmacol Biochem Behav. 2014;124:290-296.

Faron-Gorecka A, Kusmider M, Inan SY, Siwanowicz J, Piwowarczyk T, Dziedzicka-Wasylewska M. Long-term exposure of rats to tramadol alters brain dopamine and alpha 1-adrenoceptor function that may be related to antidepressant potency. Eur J Pharmacol. 2004;501:103-110.

Gopalraju P, Lalitha RM, Prasad K, Ranganath K. Comparative study of intravenous tramadol versus ketorolac for preventing postoperative pain after third molar surgery – A prospective randomized study. J Craniomaxillofac Surg. 2014;42:629-633.

Nakamura A, Narita M, Miyoshi K, Shindo K, Okutsu D, Suzuki M, et al. Changes in the rewarding effects induced by tramadol and its active metabolite M1 after sciatic nerve injury in mice. Psychopharmacology. 2008;200:307-316.

Lee EY, Lee EB, Park BJ, Lee CK, Yoo B, Lim MK, et al. Tramadol 37.5-mg/acetaminophen 325-mg combination tablets added to regular therapy for rheumatoid arthritis pain: A 1-Week, randomized, double-blind, placebo-controlled trial. Clin Ther. 2006;28:2052-2060.

Mortelmans LJ, Desruelles D, Baert JA, Hente KR, Tailly GG. Use of tramadol drip in controlling renal colic pain. J Endourol. 2006;20:1010-1015.

Hyup Lee J, Lee CS. A Randomized, Double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of the extended-release tramadol hydrochloride/acetaminophen fixed-dose combination tablet for the treatment of chronic low back pain. Clin Ther. 2013;35:1830-1840.

Kaneko K, Umehara M, Homan T, Okamoto K, Oka M, Oyama T. The analgesic effect of tramadol in animal models of neuropathic pain and fibromyalgia. Neurosci Lett. 2014;562:28-33.

Lofwall MR, Babalonis S, Nuzzo PA, Siegel A, Campbell C, Walsh SL. Efficacy of extended-release tramadol for treatment of prescription opioid withdrawal: A two-phase randomized controlled trial. Drug Alcohol Depend. 2013;133:188-197.

Seifi M, Hassanpour Moghadam M, Hadizadeh F, Ali-Asgari S, Aboli J, Mohajeri SA. Preparation and study of tramadol imprinted micro-and nanoparticles by precipitation polymerization: microwave irradiation and conventional heating method. Int J Pharm. 2014;471:37-44.

Fawzi MM. Some medicolegal aspects concerning tramadol abuse: The new Middle East youth plague 2010. An egyptian overview. Egyptian Journal of Forensic Sciences. 2011;1:99-102.

Bar-Or D, Salottolo KM, Orlando A, Winkler JV. A randomized double-blind, placebo-controlled multicenter study to evaluate the efficacy and safety of two doses of the tramadol orally disintegrating tablet for the treatment of premature ejaculation within less than 2 minutes. Eur Urol. 2012;61: 736-743.

Abel T, Lattal KM. Molecular mechanisms of memory acquisition, consolidation and retrieval. Curr Opin Neurobiol. 2001;11:180-187.

Hosseini-Sharifabad A, Ghahremani MH, Sabzevari O, Naghdi N, Abdollahi M, Beyer C, et al. Effects of protein kinase A and G inhibitors on hippocampal cholinergic markers expressions in rolipram- and sildenafil-induced spatial memory improvement. Pharmacol Biochem Behav. 2012;101:311-319.

Jafari-Sabet M, Jannat-Dastjerdi I. Muscimol state-dependent memory: involvement of dorsal hippocampal mu-opioid receptors. Behav Brain Res. 2009;202:5-210.

Sardari M, Rezayof A, Khodagholi F, Zarrindast MR. Basolateral amygdala GABA-A receptors mediate stress-induced memory retrieval impairment in rats. Int J Neuropsychopharmacol. 2014;17: 603-612.

Makkar SR, Zhang SQ, Cranney J. Behavioral and neural analysis of GABA in the acquisition, consolidation, reconsolidation, and extinction of fear memory. Neuropsychopharmacology. 2010;35:1625-1652.

Chavant F, Favreliere S, Lafay-Chebassier C, Plazanet C, Perault-Pochat MC. Memory disorders associated with consumption of drugs: updating through a case/noncase study in the French PharmacoVigilance Database. Br J Clin Pharmacol. 2011;72:898-904.

Hritcu L, Clicinschi M, Nabeshima T. Brain serotonin depletion impairs short-term memory, but not long-term memory in rats. Physiol Behav. 2007;91:652-657.

Ogren SO. Central serotonin neurones in avoidance learning: interactions with noradrenaline and dopamine neurones. Pharmacol Biochem Behav. 1985;23:107-123.

Birthelmer A, Stemmelin J, Jackisch R, Cassel JC. Presynaptic modulation of acetylcholine, noradrenaline, and serotonin release in the hippocampus of aged rats with various levels of memory impairments. Brain Res Bull. 2003;60: 283-296.

Gasbarri A, Sulli A, Innocenzi R, Pacitti C, Brioni JD. Spatial memory impairment induced by lesion of the mesohippocampal dopaminergic system in the rat. Neuroscience. 1996;74:1037-1044.

Dubrovina NI, Ilyutchenok RY. Dopamine and opioid regulation of the memory retrieval recovery in mice. Behav Brain Res. 1996;79:23-29.

Ichihara K, Nabeshima T, Kameyama T. Effects of haloperidol, sulpiride and SCH 23390 on passive avoidance learning in mice. Eur J Pharmacol. 1988;151:435-442.

Abdel-Ghany R, Nabil M, Abdel-Aal M, Barakat W. Nalbuphine could decrease the rewarding effect induced by tramadol in mice while enhancing its antinociceptive activity. Eur J Pharmacol. 2015;758:11-15.

Flood JF, Cherkin A, Morley JE. Antagonism of endogenous opioids modulates memory processing. Brain Res. 1987;422:218-234.

Jesse CR, Bortolatto CF, Savegnago L, Rocha JB, Nogueira CW. Involvement of L-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of tramadol in the rat forced swimming test. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:1838-1843.

KatzenPerez KR, Jacobs DW, Lincoln A, Ellis RJ. Opioid blockade improves human recognition memory following physiological arousal. Pharmacol Biochemi Behav. 2001;70:77-84.

Sepehrizadeh Z, Sahebgharani M, Ahmadi S, Shapourabadi MB, Bozchlou SH, Zarrindast MR. Morphine-induced behavioral sensitization increased the mRNA expression of NMDA receptor subunits in the rat amygdala. Pharmacology. 2008;81:333-343.

Nava-Mesa MO, Lamprea MR, Munera A. Divergent short- and long-term effects of acute stress in object recognition memory are mediated by endogenous opioid system activation. Neurobiol Learn Mem. 2013;106:185-192.

Grayson B, Idris NF, Neill JC. Atypical antipsychotics attenuate a sub-chronic PCP-induced cognitive deficit in the novel object recognition task in the rat. Behav Brain Res. 2007;184:31-38.

Ennaceur A, Neave N, Aggleton JP. Spontaneous object recognition and object location memory in rats: the effects of lesions in the cingulate cortices, the medial prefrontal cortex, the cingulum bundle and the fornix. Exp Brain Res. 1997;113:509-519.

Şık A, van Nieuwehuyzen P, Prickaerts J, Blokland A. Performance of different mouse strains in an object recognition task. Behav Brain Res. 2003;147:49-54.

Rutten K, Prickaerts J, Hendrix M, van der Staay FJ, Sik A, Blokland A. Time-dependent involvement of cAMP and cGMP in consolidation of object memory: studies using selective phosphodiesterase type 2, 4 and 5 inhibitors. Eur J Pharmacol. 2007;558:107-112.

Antunes M, Biala G. The novel object recognition memory: neurobiology, test procedure, and its modifications. Cogn Process. 2012;13:93-110.

Bertaina-Anglade V, Enjuanes E, Morillon D, Drieu la Rochelle C. The object recognition task in rats and mice: A simple and rapid model in safety pharmacology to detect amnesic properties of a new chemical entity. J Pharmacol Toxicol Meth. 2006;54:99-105.

Ghamati L, Hajali V, Sheibani V, Esmaeilpour K, Sepehri G, Shojaee M. Single and repeated ultra-rapid detoxification prevents cognitive impairment in morphine addicted rats: a privilege for single detoxification. Addict Health. 2014;6:54-64.

Yan T, Huan X, Wei J, Yun-cheng NI, Wei-feng Q, Peng-cheng W, et al. Effect of Tramadol with different doses on the learning and memory of mice. Journal of Jinggangshan University (Natural Science). 2011;3:28.

Zakaryaee H, Mollazadeh J, Aflakseir A, Khormaei, F, Soofi, A. Cognitive impairment in methamphetamine buprenorphin and tramadol users. Eur J Sci Res. 2012; 68:321-327.

Ng KF, Yuen TS, Ng VM. A comparison of postoperative cognitive function and pain relief with fentanyl or tramadol patient-controlled analgesia. J Clin Anesthesia. 2006;18:205-210.

Antunes M, Biala G. The novel object recognition memory: neurobiology, test procedure, and its modifications. Cogn Process. 2012;13:93-110.

Liang M, Zheng N, Xiangyang C, Liang L, Yan L, Ming J. Determination of tramadol by capillary GC-FID and a study of postmortem distribution in rats. Rom J Leg Med. 2011;19:45-50.

Minami K, Uezono Y, Ueta Y. Pharmacological aspects of the effects of tramadol on G-protein coupled receptors. J Pharmacol Sci. 2007;103:253-260.

Minami K, Uezono Y. The recent progress in research on effects of anesthetics and analgesics on G protein-coupled receptors. J Anesth. 2013;27:284-292.

Reisine T, Bell GI. Molecular biology of opioid receptors. Trends Neurosci. 1993;16:506-510.

Bernabeu R, Schmitz P, Faillace MP, Izquierdo I, Medina JH. Hippocampal cGMP and cAMP are differentially involved in memory processing of inhibitory avoidance learning. Neuroreport. 1996;7:585-588.

Nakamura M, Minami K, Uezono Y, Horishita T, Ogata J, Shiraishi M, et al. The effects of the tramadol metabolite O-desmethyl tramadol on muscarinic receptor-induced responses in Xenopus oocytes expressing cloned M1 or M3 receptors. Anesth Analg. 2005;101:180-186.

Shiraishi M, Minami K, Uezono Y, Yanagihara N, Shigematsu A. Inhibition by tramadol of muscarinic receptor-induced responses in cultured adrenal medullary cells and in Xenopus laevis oocytes expressing cloned M1 receptors. J Pharmacol Exp Ther. 2001;299:255-260.

McGaugh JL, Introini-Collison IB, Cahill LF, Castellano C, Dalmaz C, Parent MB, et al. Neuromodulatory systems and memory storage: Role of the amygdala. Behav Brain Res. 1993;58:81-90.

Farahmandfar M, Karimian SM, Naghdi N, Zarrindast MR, Kadivar M. Morphine-induced impairment of spatial memory acquisition reversed by morphine sensitization in rats. Behav Brain Res. 2010;211:156-163.

Hasanein P, Ghafari-Vahed M. Fatty acid amide hydrolase inhibitor URB597 prevented tolerance and cognitive deficits induced by chronic morphine administration in rats. Behav Pharmacol. 2015;25. [Epub ahead of print].

Ma MX, Chen YM, He J, Zeng T, Wang JH. Effects of morphine and its withdrawal on Y-maze spatial recognition memory in mice. Neuroscience. 2007;147:1059-1065.

Stafford K, Gomes AB, Shen J, Yoburn BC. μ-Opioid receptor down regulation contributes to opioid tolerance in vivo. Pharmacol. Biochem. Behav. 2001;69:233-237.

Bernstein MA, Welch SP. μ-Opioid receptor down-regulation and cAMP-dependent protein kinase phosphorylation in a mouse model of chronic morphine tolerance. Brain Res Mol Brain Res. 1998;55:237-242.

Soodi M, Naghdi N, Hajimehdipoor H, Choopani S, Sahraei E. Memory-improving activity of Melissa officinalis extract in naïve and scopolamine-treated rats. Res Pharm Sci. 2014;9:107-114.

Lo Conte G, Bartolini L, Casamenti F, Marconcini-Pepeu I, Pepeu G. Lesions of cholinergic forebrain nuclei: Changes in avoidance behavior and scopolamine actions. Pharmacol Biochem Behav. 1982;17:933-937.

Pepeu G, Giovannini MG. Cholinesterase inhibitors and memory. Chem Biol Interact. 2010;187: 403-408.

Liu J, Ho WL, Lee NTK, Carlier PR, Pang YP, Han YF. Bis(7)-tacrine, a novel acetylcholinesterase inhibitor, reverses AF64A-induced deficits in navigational memory in rats. Neurosci Lett. 2000;282:165-168.

Ragozzino ME, Gold PE. Glucose injections into the medial septum reverse the effects of intraseptal morphine infusions on hippocampal acetylcholine output and memory. Neuroscience. 1995;68:981-988.

Kondziella D, Hammer J, Sletvold O, Sonnewald U. The pentylenetetrazole-kindling model of epilepsy in SAMP8 mice: glial–neuronal metabolic interactions. Neurochem Int. 2003;43:629-637.

Manocha A, Sharma KK, Mediratta PK. On the mechanism of anticonvulsant effect of tramadol in mice. Pharmacol Biochem Behav. 2005;82:74-81.

Krogsgaard-Larsen P, Fr∅lund B, Kristiansen U, Frydenvang K, Ebert B. GABA A and GABA B receptor agonists, partial agonists, antagonists and modulators: design and therapeutic prospects. Eur J Pharm Sci. 1997;5:355-384.

Zarrindast MR, Hoghooghi V, Rezayof A. Inhibition of morphine-induced amnesia in morphine-sensitized mice: involvement of dorsal hippocampal GABAergic receptors. Neuropharmacology. 2008;54:569–576.


  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Creative Commons LicenseThis work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.